Chembio Diagnostics, Inc.

Chembio supports CDC's recommendation for routine HIV testing

Published in AIDS Weekly and Law, June 8th, 2006

Chembio Diagnostics, Inc. (CEMI) supports the U.S. Centers for Disease Control and Prevention (CDC) plans to issue revised HIV testing guidelines which recommend that doctors begin voluntary HIV testing as a part of routine medical care, for everyone in the United States between the ages of 13 to 64.

Lawrence Siebert, president and CEO of Chembio, commented, "We are pleased the CDC will be revising its guidelines so as to recommend routine HIV testing. Routine testing will lead to early diagnosis, which is essential in the battle against AIDS. Individual awareness of HIV status reduces the spread of the disease and prolongs life. With the cost of antiretroviral drugs...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly and Law

Source: AIDS Weekly and Law (2006-06-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry